NantHealth, Inc. (15) | Uncategorized (6)
- Description of Securities (Filed With SEC on February 25, 2022)
- Open Market Sale Agreement (Filed With SEC on November 12, 2021)
- Description of Securities (Filed With SEC on February 26, 2021)
- Amendment No. 3 to Second Amended and Restated NantOmics Exclusive Reseller Agreement dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
- Description of Securities (Filed With SEC on February 28, 2020)
- Amendment no. 2 to Second Amended and Restated Nantomics Exclusive Reseller Agreement (Filed With SEC on May 9, 2019)
